MRC Centre for Drug Safety Science and Institute of Translational Medicine
Jean Sathish has not added Biography.
If you are Jean Sathish and would like to personalize this page please email our Author Liaison for assistance.
Antibody cross-linking of human platelet P-selectin induces calcium entry by a mechanism dependent upon Fcgamma receptor IIA.
Thrombosis and haemostasis Sep, 2004 | Pubmed ID: 15351857
CD22 is a functional ligand for SH2 domain-containing protein-tyrosine phosphatase-1 in primary T cells.
The Journal of biological chemistry Nov, 2004 | Pubmed ID: 15364920
The whys and wherefores of phosphate removal. Meeting on The Biology of Phosphatases.
EMBO reports Mar, 2006 | Pubmed ID: 16485024
Loss of Src homology region 2 domain-containing protein tyrosine phosphatase-1 increases CD8+ T cell-APC conjugate formation and is associated with enhanced in vivo CTL function.
Journal of immunology (Baltimore, Md. : 1950) Jan, 2007 | Pubmed ID: 17182570
High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo.
Toxicological sciences : an official journal of the Society of Toxicology Dec, 2009 | Pubmed ID: 19783637
Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism.
Journal of immunology (Baltimore, Md. : 1950) Dec, 2010 | Pubmed ID: 20980635
Loss of transcription factor nuclear factor-erythroid 2 (NF-E2) p45-related factor-2 (Nrf2) leads to dysregulation of immune functions, redox homeostasis, and intracellular signaling in dendritic cells.
The Journal of biological chemistry Mar, 2012 | Pubmed ID: 22311972
Chronic inflammatory pain is associated with increased excitability and hyperpolarization-activated current (Ih) in C- but not Aδ-nociceptors.
Pain Apr, 2012 | Pubmed ID: 22377439
Immunogenicity to biologics: mechanisms, prediction and reduction.
Archivum immunologiae et therapiae experimentalis Oct, 2012 | Pubmed ID: 22930363
Challenges and approaches for the development of safer immunomodulatory biologics.
Nature reviews. Drug discovery Apr, 2013 | Pubmed ID: 23535934
Immunoglobulin G1 and immunoglobulin G4 antibodies in multiple sclerosis patients treated with IFNβ interact with the endogenous cytokine and activate complement.
Clinical immunology (Orlando, Fla.) Aug, 2013 | Pubmed ID: 23770627
Nuclear factor-erythroid 2 (NF-E2) p45-related factor-2 (Nrf2) modulates dendritic cell immune function through regulation of p38 MAPK-cAMP-responsive element binding protein/activating transcription factor 1 signaling.
The Journal of biological chemistry Aug, 2013 | Pubmed ID: 23775080
Heme oxygenase-1 regulates dendritic cell function through modulation of p38 MAPK-CREB/ATF1 signaling.
The Journal of biological chemistry Jun, 2014 | Pubmed ID: 24719331
Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonist.
mAbs , 2014 | Pubmed ID: 25517314
Development of interferon beta-neutralising antibodies in multiple sclerosis--a systematic review and meta-analysis.
European journal of clinical pharmacology Nov, 2015 | Pubmed ID: 26268445
Michael P. Storm1,
Ian Sorrell2,
Rebecca Shipley3,
Sophie Regan2,
Kim A. Luetchford1,
Jean Sathish2,
Steven Webb4,
Marianne J. Ellis1
1Department of Chemical Engineering and Centre for Regenerative Medicine, University of Bath,
2MRC Centre for Drug Safety Science and Institute of Translational Medicine, University of Liverpool,
3Mechanical Engineering, University College London,
4Department of Applied Mathematics, Liverpool John Moores University
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved